Early Confirmed Keynote Presenters
Rachael A. Clark, MD, PhD, Brigham and Women's Hospital
T-Cell Repertories in Cancer
Bahija Jallal, PhD, President, Medimmune and Executive Vice President, AstraZeneca
Antibody Development Pipeline
Sally Ward, PhD, UT Southwestern Medical Center
An Interdisciplinary Approach to Developing Therapeutics for Autoimmunity and Cancer
FAST-TRACK YOUR ANTIBODY RESEARCH TO THE CLINIC AND BEYOND
The Most Innovative Science Presented by Leading Industry and Academic Experts
Expand your pipeline of antibody therapeutics by hearing 125+ case studies, new data and industry updates from experts working across the entire spectrum of antibody development and production.
The Largest Exhibition Devoted to Antibody Engineering
Accelerate your promising therapeutic towards commercial success by connecting with leading 60+ technology and service providers.
The Leading Forum to Partner with Global Antibody Innovators and Suppliers
Fast-track your antibody research to the clinic and beyond by collaborating with 800+ attendees from leading pharma, biotechs, academia and solution providers from North America, Asia and Europe
Taylor Gray, Adimab,LLC
“This was a great conference for people of all experience levels in this field. The talks covered a wide range of topics and gave me a great overview of current happenings in antibody engineering. I am coming away from this conference with a good understanding of where this field currently is and where it is going."
Claire Nauman, Adimab, LLC
"A well-organized conference packed with informative and interesting talks, presented in an accessible format that facilitates networking and communication."
Liz Wilson, Agensys
"A great program that was very dense and informative on the emerging topics in the field of antibody therapeutics."
Rossana Nadell, Agensys
"This was an interesting conference bringing people together from UK, Germany and USA. The topics were mostly antibody/antigen-related and up to date."
Jian Yao, TopAlliance Biosciences
"Great conference, topics are well-chosen and cover a broad spectrum of interests. Plenty of opportunities to interact with other attendees. This is the conference to go to if you need to keep up with the fast-paced therapeutic antibody industry."
Marco Thomann, Roche Diagnostics, Germany
"Great conference, well-balanced between industry and academic, with interesting topics and really good speakers!"
Mark Cobbold, University of Birmingham
"One of the best conferences I have attended. A fantastic venue, program and conference designed to optimize networking and keep you up-to-date in the field."
About the Antibody Society
The Antibody Society is an international, non-profit association representing individuals and organizations involved in antibody-related research and development. Our members serve as the Scientific Advisors for the Antibody Engineering & Therapeutics (US) and the Antibody Engineering & Therapeutics Europe conferences. To provide additional opportunities for education and networking, we contribute scientific content and financial support for other conferences that cover topics relevant to antibody R&D, and are hosted by non-profit organizations. We research and analyze data on targeted therapeutics developed by the biopharmaceutical industry, and distribute our results and opinion via the Society’s website, presentations and publications. The Society also engages with government and international agencies on matters of importance to the antibody community.
Become an Event Sponsor or Exhibitor at Our 2018 Meeting
Highlight your products and services to 900+ antibody scientists and executives from North America, Asia and Europe. To request a 2017 floor plan, or to see a list of available package options, please contact Aimee Croke at Aimee.Croke@knect365.com or +1-857-504-6697.
Hotel and Venue
Manchester Grand Hyatt San Diego
1 Market Place, San Diego, CA 92101
Phone: (888) 421 -1442